ARTICLE
22 September 2022

Bridge To Bond Facilities

MF
Morrison & Foerster LLP

Contributor

Known for providing cutting-edge legal advice on matters that are redefining industries, Morrison & Foerster has 17 offices located in the United States, Asia, and Europe. Our clients include Fortune 100 companies, leading tech and life sciences companies, and some of the largest financial institutions. We also represent investment funds and startups.
John Burge and Matthew Dunlap authored an article for LexisNexis providing up to date legal information on bridge to bond facilities.
UK Finance and Banking
To print this article, all you need is to be registered or login on Mondaq.com.

John Burge and Matthew Dunlap authored an article for LexisNexis providing up to date legal information on bridge to bond facilities.

A bridge to bond facility is a type of acquisition financing where the buyer requires the certainty of a fully committed financing package, but which is intended to be replaced in the future with a mid- to long-term financing in the form of high yield bonds. In markets where acquisitions do not require a financing condition, a bridge financing package (which is available to be drawn if necessary) often remains a key component to a successful bid.

Click here to read the full article.

Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Morrison & Foerster LLP. All rights reserved

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

ARTICLE
22 September 2022

Bridge To Bond Facilities

UK Finance and Banking

Contributor

Known for providing cutting-edge legal advice on matters that are redefining industries, Morrison & Foerster has 17 offices located in the United States, Asia, and Europe. Our clients include Fortune 100 companies, leading tech and life sciences companies, and some of the largest financial institutions. We also represent investment funds and startups.
See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More